Stay updated on A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Sign up to get notified when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.

Latest updates to the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, which appears to be a minor page version change. This update does not modify study details, eligibility criteria, or outcome measures available on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded the Last Update Posted field and removed the Last Update Posted (Estimated) field on the study page. This is a metadata display change and does not alter study information or functionality.SummaryDifference0.0%

- Check41 days agoChange DetectedMinor site revision from v3.3.3 to v3.3.4; no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a consolidated Locations section with state site listings (California, Colorado, Georgia, Maryland, Missouri, New York, Ohio, Pennsylvania, Texas) and removed the individual state Locations entries and the HHS Vulnerability Disclosure link.SummaryDifference0.8%

- Check84 days agoChange DetectedAdded detailed endpoints and measurement descriptions for pruritus, sleep, and growth, along with updated timing and PRO/ObsRO instruments; also added sponsor/publications data and update timestamps. Removed the EU/RO primary endpoint definition for pruritus assessments.SummaryDifference2%

Stay in the know with updates to A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.